PACC exhibits a higher frequency of BRCA1/2 mutations compared to PDAC and is more likely to be an associated cancer of hereditary breast and ovarian cancer syndrome (HBOC). This evidence concerns the gene BRCA1 and Hereditary breast and ovarian cancer syndrome.